CRC has an immunosuppressive TME which stops the event of an effective response to ICB therapies. There is certainly thus an urgent need to identify the methods reprogram this suppressive TME as a way to improve immunotherapy efficacy. In the current analyze, we applied CRISPR KO screens to discover genes https://yasseru752mrv6.mycoolwiki.com/user